Comparative in vitro study on magnetic iron oxide nanoparticles for mri tracking of adipose tissue-derived progenitor cells

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Kasten, Annika ^a   Grüttner, Cordula ^b   Kühn, Jens Peter ^c   Bader, Rainer ^a   Pasold, Juliane ^a   Frerich, Bernhard ^a  

^a ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

^b MICROMOD PARTIKELTECHNOLOGIE GMBH   (Germany)

^c UNIVERSITY MEDICINE GREIFSWALD   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 2; IRON OXIDE; MAGNETIC IRON OXIDE NANOPARTICLE; MAGNETIC NANOPARTICLE; MESSENGER RNA; UNCLASSIFIED DRUG; FERRIC ION; FERRIC OXIDE; METAL NANOPARTICLE;

ADIPOSE DERIVED STEM CELL; ARTICLE; CALCIFICATION; CELL DIFFERENTIATION; CELL LABELING; CELL PROLIFERATION; CELL TRACKING; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; LIPID STORAGE; NUCLEAR MAGNETIC RESONANCE IMAGING; ADIPOSE TISSUE; CHEMISTRY; COMPARATIVE STUDY; CYTOLOGY; FEMALE; MAGNETISM; MALE; STEM CELL;

ADIPOSE TISSUE; CELL DIFFERENTIATION; FEMALE; FERRIC COMPOUNDS; HUMANS; IN VITRO TECHNIQUES; MAGNETIC RESONANCE IMAGING; MAGNETICS; MALE; METAL NANOPARTICLES; STEM CELLS;

EID: 84907908975     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0108055     Document Type: Article

References (56)

1. Choi JH, Gimble JM, Lee K, Marra KG, Rubin JP, et al. (2010) Adipose tissue engineering for soft tissue regeneration. Tissue Eng Part B Rev 16: 413-426.
2. Jasmin, Torres AL, Nunes HM, Passipieri JA, Jelicks LA, et al. (2011) Optimized labeling of bone marrow mesenchymal cells with superparamagnetic iron oxide nanoparticles and in vivo visualization by magnetic resonance imaging. J Nanobiotechnology 9: 4.
3. Gupta AK, Gupta M (2005) Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 26: 3995-4021.
4. Ferreira L, Karp JM, Nobre L, Langer R (2008) New opportunities: the use of nanotechnologies to manipulate and track stem cells. Cell Stem Cell 3: 136-146.
5. Wood JC, Enriquez C, Ghugre N, Tyzka JM, Carson S, et al. (2005) MRI R2 and R2∗ mapping accurately estimates hepatic iron concentration in transfusiondependent thalassemia and sickle cell disease patients. Blood 106: 1460-1465.
6. Thorek DL, Chen AK, Czupryna J, Tsourkas A (2006) Superparamagnetic iron oxide nanoparticle probes for molecular imaging. Ann Biomed Eng 34: 23-38.
7. Babic M, Horak D, Trchova M, Jendelova P, Glogarova K, et al. (2008) Poly(L-lysine)-modified iron oxide nanoparticles for stem cell labeling. Bioconjug Chem 19: 740-750.
8. Arbab AS, Yocum GT, Rad AM, Khakoo AY, Fellowes V, et al. (2005) Labeling of cells with ferumoxides-protamine sulfate complexes does not inhibit function or differentiation capacity of hematopoietic or mesenchymal stem cells. NMR Biomed 18: 553-559.
9. Sibov TT, Miyaki LA, Mamani JB, Marti LC, Sardinha LR, et al. (2012) Evaluation of umbilical cord mesenchymal stem cell labeling with superparamagnetic iron oxide nanoparticles coated with dextran and complexed with Poly-L-lysine. Einstein (Sao Paulo) 10: 180-188.
10. Riviere C, Boudghene FP, Gazeau F, Roger J, Pons JN, et al. (2005) Iron oxide nanoparticle-labeled rat smooth muscle cells: cardiac MR imaging for cell graft monitoring and quantitation. Radiology 235: 959-967.
11. Soenen SJ, Illyes E, Vercauteren D, Braeckmans K, Majer Z, et al. (2009) The role of nanoparticle concentration-dependent induction of cellular stress in the internalization of non-toxic cationic magnetoliposomes. Biomaterials 30: 6803-6813.
12. Soenen SJ, Nuytten N, De Meyer SF, De Smedt SC, De Cuyper M (2010) High intracellular iron oxide nanoparticle concentrations affect cellular cytoskeleton and focal adhesion kinase-mediated signaling. Small 6: 832-842.
13. Schafer R, Kehlbach R, Muller M, Bantleon R, Kluba T, et al. (2009) Labeling of human mesenchymal stromal cells with superparamagnetic iron oxide leads to a decrease in migration capacity and colony formation ability. Cytotherapy 11: 68-78.
14. Kostura L, Kraitchman DL, Mackay AM, Pittenger MF, Bulte JW (2004) Feridex labeling of mesenchymal stem cells inhibits chondrogenesis but not adipogenesis or osteogenesis. NMR Biomed 17: 513-517.
15. Bulte JW, Kraitchman DL, Mackay AM, Pittenger MF (2004) Chondrogenic differentiation of mesenchymal stem cells is inhibited after magnetic labeling with ferumoxides. Blood 104: 3410-3412; author reply 3412-3413.
16. Bordelon DE, Cornejo C, Grüttner C, Westphal F, De Weese TL, et al. (2011) Magnetic nanoparticle heating effiency reveals magneto-structural differences when characterized with wide ranging and high amplitude alternating magnetic fields. Journal of Applied Physics 109: 124904-124901.
17. Molday RS, MacKenzie D (1982) Immunospecific ferromagnetic iron-dextran reagents for the labeling and magnetic separation of cells. J Immunol Methods 52: 353-367.
18. Grüttner C, Müller K, Teller J, Westphal F, Foreman A, et al. (2007) Synthesis and antibody conjugation of magnetic nanoparticles with improved specific power absorption rates for alternating magnetic field cancer therapy. Fournal of Magnetism and Magnetic Materials 311: 181-186.
19. Hedayati M, Thomas O, Abubaker-Sharif B, Zhou H, Cornejo C, et al. (2013) The effect of cell cluster size on intracellular nanoparticle-mediated hyperthermia: is it possible to treat microscopic tumors? Nanomedicine (Lond) 8: 29-41.
20. Weinzierl K, Hemprich A, Frerich B (2006) Bone engineering with adipose tissue derived stromal cells. J Craniomaxillofac Surg 34: 466-471.
21. Vigor KL, Kyrtatos PG, Minogue S, Al-Jamal KT, Kogelberg H, et al. (2010) Nanoparticles functionalized with recombinant single chain Fv antibody fragments (scFv) for the magnetic resonance imaging of cancer cells. Biomaterials 31: 1307-1315.
22. Hernando D, Kuhn JP, Mensel B, Volzke H, Puls R, et al. (2013) R2∗ estimation using "in-phase" echoes in the presence of fat: the effects of complex spectrum of fat. J Magn Reson Imaging 37: 717-726.
23. Kuhn JP, Hernando D, Munoz del Rio A, Evert M, Kannengiesser S, et al. (2012) Effect of multipeak spectral modeling of fat for liver iron and fat quantification: correlation of biopsy with MR imaging results. Radiology 265: 133-142.
24. Arbab AS, Wilson LB, Ashari P, Jordan EK, Lewis BK, et al. (2005) A model of lysosomal metabolism of dextran coated superparamagnetic iron oxide (SPIO) nanoparticles: implications for cellular magnetic resonance imaging. NMR Biomed 18: 383-389.
25. Himmelreich U, Dresselaers T (2009) Cell labeling and tracking for experimental models using magnetic resonance imaging. Methods 48: 112-124.
26. Laurent S, Mahmoudi M (2011) Superparamagnetic iron oxide nanoparticles: promises for diagnosis and treatment of cancer. Int J Mol Epidemiol Genet 2: 367-390.
27. Zhang H, Li J, Sun W, Hu Y, Zhang G, et al. (2014) Hyaluronic acid-modified magnetic iron oxide nanoparticles for MR imaging of surgically induced endometriosis model in rats. PLoS One 9: e94718.
28. Al Faraj A, Sultana Shaik A, Pureza MA, Alnafea M, Halwani R (2014) Preferential macrophage recruitment and polarization in LPS-induced animal model for COPD: noninvasive tracking using MRI. PLoS One 9: e90829.
29. Liu T, Choi H, Zhou R, Chen IW (2014) Quantitative evaluation of the reticuloendothelial system function with dynamic MRI. PLoS One 9: e103576.
30. Andreas K, Georgieva R, Ladwig M, Mueller S, Notter M, et al. (2012) Highly efficient magnetic stem cell labeling with citrate-coated superparamagnetic iron oxide nanoparticles for MRI tracking. Biomaterials 33: 4515-4525.
31. Thorek DL, Tsourkas A (2008) Size, charge and concentration dependent uptake of iron oxide particles by non-phagocytic cells. Biomaterials 29: 3583-3590.
32. Verma A, Stellacci F (2010) Effect of surface properties on nanoparticle-cell interactions. Small 6: 12-21.
33. Singh N, Jenkins GJ, Asadi R, Doak SH (2010) Potential toxicity of superparamagnetic iron oxide nanoparticles (SPION). Nano Rev 1: 5358.
34. Huang DM, Hsiao JK, Chen YC, Chien LY, Yao M, et al. (2009) The promotion of human mesenchymal stem cell proliferation by superparamagnetic iron oxide nanoparticles. Biomaterials 30: 3645-3651.
35. Schmidtke-Schrezenmeier G, Urban M, Musyanovych A, Mailander V, Rojewski M, et al. (2011) Labeling of mesenchymal stromal cells with iron oxide-poly(L-lactide) nanoparticles for magnetic resonance imaging: uptake, persistence, effects on cellular function and magnetic resonance imaging properties. Cytotherapy 13: 962-975.
36. Weissleder R, Stark DD, Engelstad BL, Bacon BR, Compton CC, et al. (1989) Superparamagnetic iron oxide: pharmacokinetics and toxicity. AJR Am J - Roentgenol 152: 167-173.
37. Arbab AS, Bashaw LA, Miller BR, Jordan EK, Lewis BK, et al. (2003) Characterization of biophysical and metabolic properties of cells labeled with superparamagnetic iron oxide nanoparticles and transfection agent for cellular MR imaging. Radiology 229: 838-846.
38. Li S (2010) Identification of iron-loaded ferritin as an essential mitogen for cell proliferation and postembryonic development in Drosophila. Cell Res 20: 1148-1157.
39. Kakhlon O, Gruenbaum Y, Cabantchik ZI (2001) Repression of ferritin expression increases the labile iron pool, oxidative stress, and short-term growth of human erythroleukemia cells. Blood 97: 2863-2871.
40. Emerit J, Beaumont C, Trivin F (2001) Iron metabolism, free radicals, and oxidative injury. Biomed Pharmacother 55: 333-339.
41. Kim JA, Aberg C, Salvati A, Dawson KA (2012) Role of cell cycle on the cellular uptake and dilution of nanoparticles in a cell population. Nat Nanotechnol 7: 62-68.
42. Summers HD, Rees P, Holton MD, Brown MR, Chappell SC, et al. (2011) Statistical analysis of nanoparticle dosing in a dynamic cellular system. Nat Nanotechnol 6: 170-174.
43. Huang X, Zhang F, Wang H, Niu G, Choi KY, et al. (2013) Mesenchymal stem cell-based cell engineering with multifunctional mesoporous silica nanoparticles for tumor delivery. Biomaterials 34: 1772-1780.
44. Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, et al. (2002) Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 13: 4279-4295.
45. Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, et al. (2001) Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 7: 211-228.
46. Reddy AM, Kwak BK, Shim HJ, Ahn C, Lee HS, et al. (2010) In vivo tracking of mesenchymal stem cells labeled with a novel chitosan-coated super-paramagnetic iron oxide nanoparticles using 3.0T MRI. J Korean Med Sci 25: 211-219.
47. Addicott B, Willman M, Rodriguez J, Padgett K, Han D, et al. (2011) Mesenchymal stem cell labeling and in vitro MR characterization at 1.5 T of new SPIO contrast agent: Molday ION Rhodamine-B. Contrast Media Mol Imaging 6: 7-18.
48. Chen YC, Hsiao JK, Liu HM, Lai IY, Yao M, et al. (2010) The inhibitory effect of superparamagnetic iron oxide nanoparticle (Ferucarbotran) on osteogenic differentiation and its signaling mechanism in human mesenchymal stem cells. Toxicol Appl Pharmacol 245: 272-279.
49. Boland GM, Perkins G, Hall DJ, Tuan RS (2004) Wnt 3a promotes proliferation and suppresses osteogenic differentiation of adult human mesenchymal stem cells. J Cell Biochem 93: 1210-1230.
50. de Boer J, Siddappa R, Gaspar C, van Apeldoorn A, Fodde R, et al. (2004) Wnt signaling inhibits osteogenic differentiation of human mesenchymal stem cells. Bone 34: 818-826.
51. Jiang Z, Von den Hoff JW, Torensma R, Meng L, Bian Z (2013) Wnt16 is involved in intramembranous ossification and suppresses osteoblast differentiation through the Wnt/beta-catenin pathway. J Cell Physiol 229: 384-392.
52. Brookes MJ, Boult J, Roberts K, Cooper BT, Hotchin NA, et al. (2008) A role for iron in Wnt signalling. Oncogene 27: 966-975.
53. Wang Q, Cai J, Cai XH, Chen L (2013) miR-346 Regulates Osteogenic Differentiation of Human Bone Marrow-Derived Mesenchymal Stem Cells by Targeting the Wnt/beta-Catenin Pathway. PLoS One 8: e72266.
54. Zhang WB, Zhong WJ, Wang L (2013) A signal-amplification circuit between miR-218 and Wnt/beta-catenin signal promotes Human Adipose Tissue-Derived Stem Cells Osteogenic Differentiation. Bone 58: 59-66.
55. Chang YK, Liu YP, Ho JH, Hsu SC, Lee OK (2012) Amine-surface-modified superparamagnetic iron oxide nanoparticles interfere with differentiation of human mesenchymal stem cells. J Orthop Res 30: 1499-1506.
56. Kuhn JP, Hernando D, Mensel B, Kruger PC, Ittermann T, et al. (2013) Quantitative chemical shift-encoded MRI is an accurate method to quantify hepatic steatosis. J Magn Reson Imaging 39: 1494-1501.